This is the U.S. National Stage of PCT International Application Number PCT/IB2009/007715, filed Nov. 12, 2009, which claims priority to U.S. Provisional Application No. 61/113,912, filed Nov. 12, 2008. The contents of the foregoing applications are hereby incorporated herein in their entireties.
The present invention relates generally to the field of interacting with biological tissue through the use of electrical probes, and more particularly to interacting with a neurological target through the use of microelectrode probes.
Neurostimulation is a category of medical devices that are used to transfer electric charge or electrical fields to tissue and result in a physiological change which benefits the patient, or performs a physiological measurement. Neurostimulation is used today in the cochlea, the retina, the peripheral nerve system, the spine, the brain and other parts of the body.
In a particular application of Neurostimulation, conductive electrodes are placed in contact with certain deep brain structures in order to treat certain neurological conditions. In the case of stimulating the Subthalamic Nucleus, for example, as described in U.S. Pat. No. 5,716,377, or the Globus Pallidus, for example, as described in U.S. Pat. No. 5,683,422, the therapy can treat the symptoms of Movement Disorders such as Parkinson's disease, Essential Tremor or Dystonia. In the case of stimulating the cerebellum, Hippocampus and other brain structures, the therapy can treat the symptoms of Epilepsy [Theodore, W. H., Fisher, R. S., “Brain stimulation for epilepsy”, Lancet Neurology, 3 (2), pp. 111-118, (2004).].
An implantable pulse generator supplies the electrical signal to the electrode lead in contact with the brain structure. All components are placed surgically.
In most prior art the electrode placed in contact with the brain tissue has been metallic, cylindrical, and relatively large in size (e.g., 1.5 mm in length). In many cases, the electrodes are as large as the brain structures themselves. The large size of electrodes prevents specific and precise stimulation of small brain targets such as the pedunculopontine nucleus. The resulting large electric fields and associated current paths stimulate other structures of the brain, and do not concentrate on the intended target. Furthermore, these large electrodes cannot be used to identify the targets of the brain by neural-recording because the area they cover is very large.
Current techniques that determine placement of such relatively large electrodes are accomplished cutaneously by first inserting a relatively small (e.g., 600 μm diameter probe). The relatively small probe can be inserted along an approach near the target. Recordings of neural activity can be made as the probe is advanced along the approach until the intended target is located. The depth of the probe from a reference is recorded and the relatively large electrodes are inserted along the same trajectory, being placed at the recorded depth. This process is complex, requiring a highly skilled surgeon to place both the probe and later the electrode. Repositioning and removal of the probe and reinsertion of the electrode subject the patient to heightened risk as the risk of tissue damage and bleeding is increased.
Attempts have been made at developing microfabricated devices specifically designed to incorporate an array of microelectrodes which can stimulate small volumes of tissue in the deep brain, for example, as described in U.S. Pat. App. Pub. 2007/0118197, or “Multisite Microelectrodes for Use in Human Deep Brain Stimulation” by Hofmann et al., Microtechnologies in Medicine and Biology, 2006 International Conference on (2006) Pgs. 284-287. The prior devices however do not have a clear path to clinical use because they are too unfamiliar to the neurosurgeon performing the implantation procedure.
An important requirement for a successful outcome of deep brain stimulation (DBS) treatment, is the accurate placement of the stimulation electrodes within the stimulation target area. Mislocation may result in unwanted side-effects, including sensory motor effects and mood changes. Prior art procedures approximately localize the target by pre-surgical imaging and planning to identify a trajectory to minimize risk of damage. It may be impossible to locate the exact functional anatomy within a target region of the brain. The targets themselves may be only a few mm or less, and not detectable through standard imaging techniques alone. Also, position changes of the brain may occur when surgically opening the skull to implant the electrodes and when inserting the electrodes. Current procedures insert test electrodes used to perform electrophysiological exploration of the target area. Once the precise target area is located, the chronic stimulation electrodes can be implanted at the precise location.
Disadvantages to the current technology include extension of operation time by several hours, which can be an increased burden for the patient, who is typically awake during such procedures, and extended cost associated with lengthier procedures. Increased risk of surgical complications from bleeding or tissue damage caused by repeated insertion and extraction of test and chronic leads. Possibility that chronic leads are not precisely located at identified target for any number of reasons, including further brain movement. An increased chance of infection due to an open craniotomy for several hours.
For efficient stimulation of small brain structures, small electrodes are required. After placement of the electrode lead, the surgeon should be able to identify the area of the brain that requires stimulation by recording from the electrode. Subsequently the surgeon should stimulate the identified structure.
For efficient stimulation of large brain structures, electrodes that contain a higher number of edges are provided.
The invention describes a system which places many microelectrode structures in the brain, and allows the surgeon to apply a signal to each microelectrode separately, or in parallel. Furthermore, using electronics to record neural activity from the system, the surgeon can develop a localized map of neural activity in the region which the electrode is implanted.
In one aspect, the invention relates to an implantable neurological probe. The neurological probe includes an elongated probe shaft and an arrangement of multiple microelectrode elements disposed at a distal end of the elongated probe shaft. At least one electrical contact is arranged proximally along the probe shaft. The neurological probe also includes at least one electrical conductor in electrical communication between at least one of the plurality of microelectrode elements and the at least one electrical contact.
In another aspect, the invention relates to a process for stimulating a neurological target. The process includes implanting a neurological probe within a vicinity of a neurological target site. The neurological probe itself comprising an elongated probe shaft, multiple microelectrode elements arranged at a distal end of the elongated probe shaft, at least one electrical contact arranged proximally along the probe shaft, and at least one electrical conductor in electrical communication between at least one of the multiple microelectrode elements and the at least one electrical contact. The at least one electrical contact is connected to a neurological stimulation source supplying an electrical signal. One or more of the microelectrode elements is energized by the supplied electrical signal. The one or more energized microelectrode elements produce an electric field adapted to stimulate the neurological target site.
In yet another aspect, the invention relates to an implantable neurological probe kit. The kit includes a neurological probe. The neurological probe includes an elongated flexible probe shaft having a central lumen accessible at a proximal end of the neurological probe. The device includes multiple microelectrode elements arranged at a distal end of the elongated probe shaft. At least one electrical contact arranged proximally along the probe shaft. At least one electrical conductor in electrical communication between at least one of the plurality of microelectrode elements and the at least one electrical contact. The neurological probe kit also includes a trocar, or stylet, configured for removable insertion into the central lumen of the elongated flexible probe shaft, to keep the elongated flexible probe shaft substantially rigid during insertion into biological tissue.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention, as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
Described herein are microelectrode array devices, and methods of fabrication and use of the same, to provide highly localized and efficient electrical stimulation of a neurological target, such as individual neurons, groups of neurons, and neural tissue as may be located in an animal nervous system, such as deep within a human brain. In larger brain targets such as the Globus Pallidus, or in targets that requires high levels of neural stimulation, such as Brodmann Area 25, more electrodes are required within the target itself. A higher number of electrodes, and more specifically a higher number of electrode edges, will increase the number of neurons that are captured by the electric field for either stimulation or inhibition.
The stimulation can be highly localized, because the microelectrode elements can be as small as only 2 μm or large as 2 mm in either of diameter or width. The relative spacing between such microelectrode elements can also be as small as only 2 μm or as large as 2 mm. Although 2 μm are indicated as lower limits to either dimension or spacing, other embodiments are possible having dimensions and/or inter-element spacing of less than 2 μm, as may be practically limited by fabrication techniques. Generally, microelectrodes of about 500 μm in diameter or width, with about a 500 μm spacing are particularly efficient in stimulating neural tissue. An array of such microelectrode elements may consist of one or more such elements (e.g., sixteen elements), each disposed at a respective position, or site. This is in contrast to currently available stimulation leads, such as the Model 3387 or Model 3389 DBS leads commercially available from Medtronic, Inc. of Minneapolis, Minn. Such commercially available devices include relatively large, cylindrical electrodes measuring about 1.5 mm in height, and having a maximum of only four electrodes in use today for deep brain stimulation.
Smaller microelectrode elements can be used to provide neurological stimulation that is highly localized and efficient because an array of such microelectrodes can also be used to identify the stimulation region of interest. For example, one or more microelectrode elements of such an array of microelectrode elements can be used to detect and, in some instances, record neuronal activity in the vicinity of the detecting/recording microelectrode elements. Such refinement offered by the relatively small size and/or spacing of the microelectrode elements can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. A suitably dimensioned microelectrode array having multiple microelectrode elements positioned in a general vicinity of a neurological target, can be used to locate a precise neurological target without further repositioning, by identifying those one or more microelectrode elements located in a very specific region of the neurological target. The microelectrode array can be programmed to stimulate in a very specific region, for example, using only a certain number of the microelectrode elements to actively stimulate the surrounding neurons and/or neuronal tissue, while other electrode elements of the array remain inactive.
In some embodiments, an elongated device including such a microelectrode array having elements with relatively small size and/or spacing can be used to obtain a highly localized map of neuronal activity in the region surrounding the implant. For example, such a device configured with a linear array of microelectrodes positioned along a length of a distal end of the device can be placed into a patient's brain. Preferably, the elements of the microelectrode array span a region including the neurological target. Neurological activity can then be independently detected by one or more of the microelectrode elements. The detected activity may be captured in a recorder or display device, allowing a clinician to identify which one or more of the microelectrode elements is positioned closest to the intended target. Knowing a respective location of each of the microelectrode elements along the device, and determining the distance to a reference, such as the patient's skull, a precise location of the target can be determined as the distance along a trajectory of the device, measured from the reference to the particular microelectrode element. Beneficially, location of the target can be determined without any repositioning of the elongated device, thereby simplifying the medical procedure and reducing patient risk.
In some embodiments, the device is cutaneous, being removed after the target has been located, being replaced with a chronic probe, positioned at the determined target location. Alternatively or in addition, the device itself can be left in place as a chronic device, the same microelectrodes, or different ones, being used to record and/or stimulate the neurological target over an extended period.
One embodiment of a microelectrode device illustrated in
The microelectrode probe assembly 100 is preferably sized and shaped for its intended neurological application. For example, the microelectrode probe assembly 100 may be at least partially placed within the central nervous system. Alternatively or in addition, the microelectrode probe assembly 100 may be at least partially placed within other parts of the body, such as the retina, the cochlea, the epidural space of the spine, and other locations within the peripheral nervous system. Thus the diameter and length of the microelectrode probe assembly 100 may vary depending on the particular anatomical target. Additionally, the configuration of the microelectrode array 104 is also sized and shaped for an intended neurological target. The number, shape, orientation, size, and spacing of the microelectrode elements 103 of the array 104 can be defined in response to the intended neurological target.
In at least some embodiments one or more of the microelectrode elements 103 are sized and or spaced to record from and/or stimulate a single neuron. The microelectrode probe assembly 100 can be used to detect and/or record neuronal activity at the neurological target. Neuronal activity naturally occurring within the neurological target gives rise to local electromagnetic fields that can be detected by one or more of the microelectrode elements 103 of the microelectrode array 104. For example, electric fields produced by neurons will polarize one or more of the microelectrode elements 103. Such polarization gives rise to an electrical potential with respect to a reference, such as electrical ground, or another one of the microelectrode elements 103. Such electric activity can be further conducted to one or more of the cylindrical contacts 106 through the internal electrical conductors 108. One or more of the cylindrical contacts 106, in turn, can be connected to one or more additional medical devices for further processing of the detected electrical activity. For example, the cylindrical contacts 106 can be coupled to a display device or recording device for displaying and/or recording electrical activity from the neurological target.
Alternatively or in addition, one or more of the microelectrode elements 103 can be used to electrically stimulate the neurological target. For example, one or more externally generated electrical signals can be applied to one or more of the cylindrical contacts 106. These electrical signals can be conducted through the internal electrical conductors 108 to one or more of the microelectrode elements 103 of the microelectrode array 104. Depending on the amplitude and polarity of the electrical signals, an electrical field will be induced by the polarized microelectrode elements 103. Electrical fields induced by such polarization can interact with one or more neurons at the neurological target.
A microfabrication procedure can be used to implement electrically conductive traces within an insulative substrate to form any of the microelectrode array devices described herein, whether the array devices are rigid or flexible. The microfabricated components include portions of the microelectrode array assembly. The microelectrode array can be implemented in a polymeric material such as polyimide or parylene and includes thin film or plated layers of a metal or metal oxide with high charge transfer capability such as platinum, platinum-iridium, iridium, iridium oxide or titanium. In some embodiments, other metals, metal alloys, and electrically conductive materials, such as doped semiconductors, conductive polymers, and conductive ceramics may be used. In some embodiments, the polymeric and metallic layers are deposited sequentially and formed using established principles of microfabrication such as spin coating, DC/RF sputtering, photolithography, plasma etching, and etching with a mask consisting of a secondary or sacrificial material such as silicon dioxide or photosensitive resist.
The metallic layer is formed to create one or more of the microelectrode array elements and electrically conductive traces that connect the array elements to one or more of the electronics, when included, internal electrical conductors of the elongated cylindrical member, and housing. In some embodiments, the microelectrode array includes multiple layers. For example, the polymeric layers serve to isolate the traces from each other, while also providing the structure of the implant's stimulating/recording tip. There are several fabrication methods which can be described to build such a microfabricated component.
The insulative substrate can be a polymer, such as a polyimide or parylene but can also be polyurethane or polysiloxane (silicone), or any other suitable insulator. For substantially non-flexible, or rigid embodiments, a rigid or semi-rigid substrate can be included. In some embodiments, the microelectrode array device is formed on at least one surface of a rigid substrate, such as a planar ceramic member. Alternatively or in addition, one or more rigid or semi-rigid supporting members can be attached during fabrication to provide a desired amount of rigidity. Generally, the microfabricated component can be fabricated, for example, using a series of additive and subtractive processes that produce a stack of materials.
Mechanical components of the implantable neurological probe assembly 100 include the elongated cylindrical member 102, which can be a simple polymeric cylinder. In some embodiments the cylindrical member may be composed of two concentric tubes with wire traces wrapped around the inner tube, in the space between the concentric tubes. The elongated cylindrical member 102 can vary in length and diameter but is generally at least about 28 cm long, and around 1.27 mm in diameter. In some embodiments, the microfabricated component is wrapped around an external surface of the cylindrical member 102. In some embodiments, the microfabricated component is wrapped around an additional tube at the distal end of the cylindrical member 102. Alternatively or in addition, the microfabricated components can be attached to the cylindrical member 102 to protrude at the distal tip, from the cylindrical member's interior. The cylindrical member 102 also contains electrical wires 108 within that connect at one end to the microfabricated component, at another end to the cylindrical contacts 106 for interconnection to an implantable pulse generator. In some embodiments, one or more of the microfabricated components and the elongated cylindrical member 102 include one or more electrical components.
The electrical components can be discrete or microelectronic parts. Their purpose is to filter, route, generate, or process signals to and from the microelectrodes. They can be attached to the microfabricated part during production, or bonded afterwards. They will generally be contained within the mechanical component.
The neurological probe 100 can be implanted near a neurological target, such as a target brain structure, using common neurosurgical techniques such as stereotaxy or endoscopy. The neurological probe 100 can be inserted without support, or within a supporting cannula having an inner dimension slightly larger than the outer dimension of the device. The cannula, when used, would be retracted once the neurological probe 100 has been suitably positioned. In some embodiments a lumen along the axis of the cylindrical member 102 permits the insertion of a rigid stylet which renders the neurological probe 100 rigid during surgical implantation. This is particularly helpful during insertion, positioning and repositioning of flexible embodiments of the neurological probe 100. The stylet is removed after implantation leaving the probe in its surgical target.
A clinician can connect one or more of the microelectrode elements to a display unit or a recording unit through the cylindrical contacts 126. The recording unit, not shown, allows a clinician to identify certain regions of the brain according to their electrical activity. In some embodiments, such recording information can be processed automatically, through the use of a suitably programmed computer processor. The electrodes used to record from the brain can be the same electrodes as those used to stimulate tissue. The recording electrodes can also be separate from those used to stimulate the brain. This situation might be preferred because electrodes destined for recording may be different in size and design than those for stimulation.
The operator can connect the electrodes to an external stimulation source or an implantable source. In either instance, the source can include a pulse generator for applying signals to the electrode sites. The signals from such a pulse generator can be connected directly to the electrodes, or they can be preprocessed using electronics embedded in the device. The electronics can filter certain parts of the original signal. If there are more electrodes than signals, the electronics can route or otherwise interconnect the stimulation source as necessary.
A perspective view of the portion of a human anatomy is illustrated in
Referring now to
As illustrated, one or more of the microelectrode elements 142c of the microelectrode probe assembly 140 are positioned in intimate contact with the neurological target 150. In more detail, each microelectrode element is configured here as an annular array of sub-elements 145, 151. The sub-elements 145, 151 can be distributed about a circumference of the probe assembly 140, at a common axial displacement from the distal end. It is understood that some sub-elements of such an annular array 142c can be in contact with the neurological target, while other sub-elements of the same annular array 142c are not (as shown). One or more additional microelectrode elements 142 of the probe assembly 140 may reside at locations not in the immediate vicinity of the neurological target 150. In at least some embodiments, one or more of the microelectrode elements 142 are remotely accessible from a proximal end of the probe assembly 140 via one or more electrically conductive leads (not shown).
In at least some embodiments, selectable sub-elements 145, 151 can be activated to record and or stimulate the target 150. For example, recordings of neurological activity from sub-elements 145 in contact with the target 150 can be used to identify the location of the target 150 relative to the probe assembly 140. As determined from the recordings, only those sub-elements 151 in contact with the target may be activated to stimulate the target. Depending upon the location of the target, this may result in an annular array 142 stimulating a selectable angular region about the probe assembly 140.
Any of the supporting structures described herein, such as the supporting structure 144 illustrated here can be a ridged, or semi ridged structure, such as a polymeric cylinder. Alternatively or in addition, the structure can be a flexible structure, such as one or more flexible substantially non conducting substrate (i.e., a bi-electric ribbon) onto which the microelectrode elements 142 are formed as electrically conductive film layers. The one or more microelectrode elements 142 are in communication with electronic circuitry (not shown) through one or more electrical leads (not shown) that can be routed through an internal lumen of a supporting structure 144 and/or formed using elongated film layers along a flexible, ribbon like supporting structure 144.
In some embodiments, the microelectrode elements 142 can be placed into the brain generally for recording and/or stimulation of the cortex and for deep brain stimulation and/or recording of neurological targets including the subthalamic nucleus and the globus pallidus. The microelectrode elements 142 can also be placed in other parts of the body, such as the retina, the spine, the peripheral nervous system for neural recording and/or neural stimulation of such portions of an animal anatomy. Although microelectrodes are discussed generally throughout the various embodiments, there is no intention to limit the upper or lower size of the microelectrodes. The devices and methods described herein are generally scalable, with a microelectrode size determined according to the intended application. For at least some of the neurological applications, microelectrodes are dimensioned sub-millimeter. In some embodiments, microelectrodes are dimensioned sub-micron. In some embodiments, the microelectrodes are formed as planar structures having a diameter of about 50 μm that are arranged in a linear array with center to center spacing of about 100 μm. The planar structure of the microelectrodes can have regular shapes, such as circles, ellipses, polygons, irregular shapes, or a combination of such regular and/or irregular shapes.
This probe assembly 140 is implantable near a neurological target, such as a target brain structure, using common neurosurgical techniques such as stereotaxy or endoscopy. The device might be inserted without support or within a cannula which may have an inner dimension slightly larger than the outer dimension of the device. Alternatively, or in addition to, the device may have a rigid stylet miming along its central axis with an outer diameter that is smaller than the inner diameter of an axial lumen in the device. When used, such a cannula, or a stylet, is generally retracted once the device is in position.
The operator can connect the probe assembly 140 to a recorder unit configured to identify certain regions of the neurological target (e.g., the brain) according to the electrical activity detected by the probe assembly 140. In some embodiments, the microelectrode elements 142 used to record from the neurological target 150 can be the same microelectrodes as those used to stimulate the target in applications in which both recording and stimulation are accomplished. Alternatively or in addition, the microelectrode elements 142 used to record from the neurological target 150 can be separate microelectrode elements 142 from those used to stimulate the target 150. This is demonstrated in this embodiment, in which each microelectrode assembly includes one or more recording electrodes 145 and one or more stimulating electrodes 151. As shown, the dedicated recording electrode 145 is smaller than dedicated stimulation electrode 151. In some embodiments, microelectrodes destined for recording (e.g., 145) may differ in one or more of size, shape, number, and arrangement from those microelectrodes destined for stimulation, e.g., using different microelectrodes.
The microelectrode elements 142 configured for stimulation can be connected to a stimulation source through one or more interconnecting leads. In some embodiment, at least a portion of the stimulation source can be extracorporeal. Alternatively or in addition, the stimulation source can be in vivo. Any implanted elements of the stimulation source are preferably fabricated and/or contained with a hermetically sealed, bio-compatible envelope. Such bio-compatible packaging of signal sources is well known, for example, in the area of artificial pacemakers. The stimulation source, when provided, may be a controllable signal generator producing a desired signal according to a prescribed input. For example, the signal generator may receive an input indicative of a desired output stimulation signal frequency. Such output stimulation signals can have a variety of wave forms, such as pulses, charged balanced pulses, sinusoidal, square wave, triangle wave, and combinations of such basic wave forms.
In some embodiments, the stimulation source includes a pulse generator for applying signals to the microelectrodes site. The signals from the pulse generator can be connected directly to the microelectrodes, or they can be preprocessed using electronics. In some embodiments, such preprocessing electronics are embedded within the implantable device. The preprocessing electronics can filter certain parts of an original signal, such as a cardiac pacemaker signal, in order to select preferred frequency components of the original signal that are at or near a peak resistance frequency of the microelectrodes. For embodiments in which there are more microelectrodes than signals, electronics can route the stimulation signals to preferred one or more of the microelectrodes.
Referring now to
In at least some embodiments the formable planar substrate 160 includes a longitudinal extension 164. This longitudinal extension 164 may include one or more electrical circuit elements such as one or more electrically conductive wire-lead contacts 168 as shown. One or more of the electrically conductive circuit elements, such as the wire-lead contacts 168 may be in electrical communication with one or more of the electrically conducting bands 162 through interconnecting traces 166 extending between the wire-lead contacts 168 and the electrically conducting bands 162. As illustrated, at least a portion of the microelectrode array 104 is located along an external surface of the elongated microelectrode probe assembly 100. Other portions such as the longitudinal extension 164 maybe located within an interior portion of the elongated cylindrical member 102. Four internal electrical conductors, or leads 108, are illustrated extending along an interior portion of the elongated cylindrical member 102. Distal tips of each of the internal electrical conductors 108 are in electrical communication with a respective one of the wire-lead contact 168 as illustrated.
An exemplary embodiment of a microelectrode array 180 is illustrated in
Referring next to
An alternative embodiment of a neurological probe 200 is shown in
Referring next to
Microelectrode elements 207 are not segmented, therefore one electrode covers the entire circumference of the neurological probe 200. The assembly can include an end cap 209, which covers the end of the cylindrical tubing. The assembly can also include a support tube 215 onto which the microelectrode film can be attached, e.g., by gluing or heating. In this embodiment, each contact of the eight cylindrical contacts 206 is electrically coupled to a respective one of the microelectrodes 204, 207.
Another embodiment of an elongated microelectrode probe assembly 220 is illustrated in
In more detail, referring to
One or more of the cylindrical contacts 226 can be used to communicate with the microelectronics assembly 233 through one or more of the internal electric conductors 228 in order to remotely or externally control operation of the microelectronics assembly 233. For example, an external signal may be used to select which one or more of the microelectrode contacts of the microelectrode array 230 are selected for recording. In some embodiments recording can be accomplished for all of the microelectrode contacts of the microelectrode array 230.
Alternatively or in addition, the microelectronics assembly 233 may include a multiplexer for combining the signals from more than one of the microelectrode elements 231 onto one of the cylindrical contacts 226. Alternatively or in addition, such multiplexing techniques can be used to combine one or more of the cylindrical contacts 226 to one of the microelectrode elements 231. For example, two contacts 231 can be coupled to one of the distal contacts 226, such that four contacts 226 are sufficient for accessing all eight microelectrode elements simultaneously. Such multiplexing may include any suitable form, such as time division multiplexing, frequency division multiplexing, code division multiplexing, and combinations of one or more of these techniques.
In some embodiments the microelectronics assembly 233 perform at least some level of processing of the detected neurological activity. In some embodiments the microelectronics assembly 233 may be a purely routing device connecting one or more selected microelectrode elements 231 to one or more of the cylindrical contacts 226. Such a microelectronics assembly 233 may be a simple switch or router device. Such routing may include electromechanical switches, reed switches, and electronic switches, such as transistor (e.g., field effect transistor) switches. The switches can be configured in a matrix fashion to allow one or more of the microelectrode elements 231 to be in communication with one or more of the microelectronics assembly 233 and the internal electrical conductors 228 based on a control input signal as may be received from an external source through one or more of the contacts.
In some embodiments, the microelectronic device may include signal conditioning circuitry such as one or more of amplification, filtering, and attenuation. For example, in detection or recording mode, one or more low noise preamplifiers may be included for boosting detected signal level to improve their detectability and recording quality at the cylindrical contacts 226. Such signal conditioning may include one or more of electronic filtering to tailor a frequency spectrum of the detected signal and attenuation. Such electronic filtering can be accomplished with any suitable filter known to those familiar with electronic signal processing. Such filters may include low pass, high pass, band pass and combinations of one or more of these. The filters may be implemented with standard circuit elements, such as inductors, capacitors, and resistors. Alternatively or in addition, at least some of the filters may be implemented using digital signal processing techniques.
Additional processing can be performed to assess the recorded signals and to determine the location of a preferred neurological target. Through careful configuration of the microelectronic contacts in their size, location and configuration, it is possible to locate a target neurological site. For embodiments in which the microelectrode contacts are dimensioned on the order of target neurons it may be possible to record activity of individual neurons independently. The microelectronics assembly 233 may include one or more of an Application-Specific Integrated Circuit (ASIC), commonly available electronics modules, such as microprocessors, electronic memory elements, communications devices, combinational logic, power conditioning, and the like.
An exemplary longitudinal extension of a MEMS film device is illustrated in
Another embodiment of an elongated microelectrode probe assembly 420 is illustrated in
One or more internal electrical conductors 428 extend from the microelectrode array assembly 260 to the one or more cylindrical contacts 426. The internal electrical conductors are configured so as not to interfere with interior volume of the open ended lumen 424 or with flexibility of the elongated cylindrical member 422. In the illustrated embodiment, four such electrical conductors 428 are shown extending helically along the length of the elongated cylindrical member, between the microelectrode array assembly 260 and the cylindrical contacts 426. These helically wound internal electrical conductors 428 reside within the material of the flexible elongated cylinder 422 between an exterior surface and an interior wall of the open ended lumen 424.
Beneficially, an elongated rigid guide member, such as a stylet, or trocar (not shown) can be inserted into an open end 430 of the open ended lumen 424 extending along a substantial length of the elongated flexible cylindrical member 422 to provide temporary rigidity as may be necessary during insertion and/or removal procedures of the elongated electrical probe assembly 420. When employed during an insertion procedure, such a stylet provides rigidity as the elongated electrical probe assembly 420 is inserted into a neurological target site. Once inserted at the target site, the stylet can be removed from the proximal open end 430. The remaining elongated electrical probe assembly 420 remains positioned at the target site, while also providing substantial flexibility along its extended length. Such flexibility offers advantages for patient comfort and response to any movement of the local anatomy to promote prolonged placement of the microelectrode array assembly 260 at the neurological target site. The stylet may be configured as a straight element. In some embodiments, at least a portion of the stylet may include a non-linear region, such as a curve, as may be beneficial to facilitate insertion and/or removal of the elongated electrical probe assembly 420.
As shown, the microelectrode array assembly 260 extends for a length ‘T’ along longitudinal axis. The elongated flexible cylindrical member 422 has a diameter ‘D’. Four cylindrical contacts 426 at the proximal end can provide access to power 426a, electrical ground 426b, control 426c, and signal or data 426d.
A more detailed view of a distal portion of the elongated electrical probe assembly 420 shown in
A more detailed illustration of an embodiment of the distal end of the elongated probe assembly 420 is shown in
A more detailed illustration of the assembled microelectrode film 260 is illustrated in
In some embodiments, each stimulation electrode element 268 extends along an arc length greater than 10° but less than 180°. Each recording electrode 269 extends along an arc length substantially less than 90° such that the combination of stimulation electrode elements 268 and recording electrode elements 269 are disposed about 360° of the cylindrical substrate 262 with suitable spacing provided between each of the adjacent elements 268, 269. As illustrated, the stimulation electrode elements 268 appear as stripes located about their respective distances along the central axis; whereas, the recording electrodes appear as small circles, or dots.
The particular shape of the recording electrode elements 269 can be circular, elliptical, polygonal, such as squares, triangles, diamonds, hexagons, and the like. The shape of the stripe ends of the stimulation electrode elements 268 adjacent to the recording electrode 269 may be angular (e.g., square) or curved. As shown in the figure, a reference angle is measured with respect to a seam at 0° extending around the circumference. The recording electrodes 269 are located adjacent to the seam 264 at approximately 0°. A second recording electrode located opposite to the first resides at approximately 90°. Likewise, the stimulation electrode element 268 is centered at approximately 45°, between approximately 15° and 75°. A second stimulation electrode 268 is located centered at 135° and also extending between approximately 105° and 165°. A third recording electrode 269 is located at approximately 180°. A third stimulation electrode 268 is located centered at 225°, extending between approximately 195° and 255°. A fourth recording electrode 269 is located at approximately 270°. A fourth stimulation electrode 268 is located centered at 315° extending between approximately 285° and 345°.
Also shown is a longitudinal extension to the substrate 272 including in this example thirty two electronic device contacts 274, each one in electrical communication with a respective one of the dedicated recording or dedicated stimulating electrodes via interconnecting lead traces. Also disposed on the longitudinal extension 272 are one or more wire lead contacts 276. In the illustrative example, four such wire lead contacts 276 are provided.
Illustrated in
The electronic device 280 is in further communication with each of the four wire lead contacts 276a through 276d (generally 276). In the illustrative example, the first wire lead contact 276a is used for supplying electrical power to the microelectronic device and/or one or more of the stimulation electrode elements 268. The second wire lead contact 276b is used to provide an electrical ground contact. This ground contact 276b may include earth ground, another electrical ground within the system, such as a chassis ground of a medical device connected to the electronic device 280, or simply a signal return line. A third wire lead contact 276c corresponds to a control signal that may be used to provide control inputs from an operator or other medical device, to control configuration and/or operation of the electronic device 280. Alternatively or in addition, the control signal contact 276c may be used for control signals from the electronic device 280 to another medical device. A fourth wire lead contact 276d corresponds to a signal contact as may be used for directing electrical activity detected by one or more of the recording electrode elements 269 to a recording or display device. Alternatively or in addition, the signal contact 276d may be used for directing electrical stimulation signals from another medical device to one or more of the stimulation electrode elements 268.
Referring again to
The distal end incorporates a support tube 229, that serves as a support structure for the microelectrode film 202 and as a protective enclosure for the microelectronic circuit and connections within. In this example the tube 229 has a length of 8 mm, an inner diameter of 1.05 mm, and an outer diameter of 1.25 mm. It may be implemented in a rigid, or semi-rigid material such as stainless steel, or a biocompatible polymer such as PEEK (polyetheretherketone).
The embodiment also demonstrates the outer cylindrical member 203 which is implemented with an outer diameter of 1.27 mm, and an inner diameter of 1.05 mm. It is generally implemented in polyurethane or silicone. Along its lumen are wrapped the lead wires 221 that electrically connect the proximal and distal ends of the neurological probes. The outer cylindrical member 203 can be connected to the support tube 229 by form fitting or gluing.
The embodiment also demonstrates an end-cap 241 which can be implemented as a plug to seal the ends of the two concentric tube structures. The microelectrode film 202 is connected to the inner volume by an extension 208 that leads to the embedded microelectronic element and lead wires 221.
Referring now to
As shown in
Various configurations of the microelectrode elements are illustrated in
In the exemplary embodiment, the annular microelectrode pattern 303 includes eight microelectrode 302 discs, each having a diameter of about 300 μm, uniformly distributed and wrapped around a 1.27 mm diameter cylinder. The microelectrodes 302 could be other shapes, such as ellipses, polygons, such as squares, triangles, diamonds, hexagons, and the like. One or more of the shapes and sizes of the microelectrodes 302 may vary within the annular microelectrode pattern 303. For example, sizes may range from 2 μm or less, to 1 mm or larger. The electronics required to apply electrical signals to the microelectrode sites, or to record neural activity from the sites, are embedded within the central cylinder.
An alternative embodiment of the invention illustrated in
Another embodiment of a microelectrode array 330 is illustrated in
It is advantageous in at least some instances to treat a target region with a probe having a greater number of edges. Edges offer certain advantages in controlling charge and/or current distributions. To this end, a microelectrode of a given surface area, can be configured to increase its perimeter. This can be accomplished, for example, by controlling shapes of the microelectrodes. Thus, rather than a simple rectangular arrangement, a microelectrode can have a folded shape (e.g., a “U” or and “S” or even a comb-like shape). In at least some embodiments, more than one microelectrode are energized by a common source (e.g., through a common bonding pad). For example, two or more of the microelectrode strips 332 can be connected to the same respective bond pad. Thus, the eight strips 332 can be controlled through only four bonding pads.
Another embodiment of a microelectrode array 340 is illustrated in
Another microelectrode structure is illustrated in
Another microelectrode structure is illustrated in
Referring to
Referring now to
Referring now to
Referring now to
The supporting structure 744 can be a ridged, or semi ridged structure, such as a an elongated, flat shaft. Alternatively or in addition, the structure can be a flexible structure, such as one or more flexible substantially non conducting substrate (i.e., a bi-electric ribbon) onto which the microelectrode elements 742 are formed as electrically conductive film layers. The one or more microelectrode elements 742 are in communication with electronic circuitry (not shown) through one or more electrical leads 746 that can be routed through an internal lumen of a supporting structure 744 and/or formed using elongated film layers along a flexible, ribbon like supporting structure 744.
In some embodiments, the microelectrode elements 742 can be placed into the brain generally for recording and/or stimulation of the cortex and for deep brain stimulation and/or recording of neurological targets including the subthalamic nucleus and the globus pallidus. The microelectrode elements 742 can also be placed in other parts of the body, such as the retina, the peripheral nervous system for neural recording and/or neural stimulation of such portions of an animal anatomy. Although microelectrodes are discussed generally throughout the various embodiments, there is no intention to limit the upper or lower size of the microelectrodes. The devices and methods described herein are generally scalable, with a microelectrode size determined according to the attended application. For at least some of the neurological applications, microelectrodes are dimensioned sub-millimeter. In some embodiments, microelectrodes are dimensioned sub-micron. In some embodiments, the microelectrodes are formed as planar structures having a diameter of about 50 μm that are arranged in a linear array with center to center spacing of about 100 μm. The planar structure of the microelectrodes can have regular shapes, such as circles, ellipses, polygons, irregular shapes, or a combination of such regular and/or irregular shapes.
This probe assembly 740 is implantable near a neurological target, such as a target brain structure, using common neurosurgical techniques such as stereotaxis or endoscopy. The device might be inserted without support or within a cannula which may have an inner dimension slightly larger than the outer dimension of the device. When used, such a cannula would be retracted once the device is in position.
The operator can connect the probe assembly 740 to a recorder unit configured to identify certain regions of the neurological target (e.g., the brain) according to the electrical activity. In some embodiments, the microelectrode elements 742 used to record from the neurological target 750 can be the same microelectrodes as those used to stimulate the target in application in which both recording and stimulation are accomplished. Alternatively or in addition, the microelectrodes 742 used to record from the neurological target 750 can be separate microelectrodes 742 from those used to stimulate the target 750. In some embodiments, microelectrodes destined for recording may differ in one or more of size, shape, number, an arrange from those microelectrodes destined for stimulation, using different microelectrodes.
The microelectrode elements 742 can be connected to a stimulation source through one or more interconnecting leads. In some embodiment, at least a portion of the stimulation source can be extracorporeal. Alternatively or in addition, the stimulation source can be in vivo. Any implanted elements of the stimulation source are preferably fabricated and/or contained with a hermetically sealed, bio-compatible envelope. Such bio-compatible packaging of signal sources is well known, for example, in the area of artificial pacemakers. The stimulation source, when provided, may be a controllable signal generator producing a desired signal according to a prescribed input. For example, the signal generator may receive an input indicative of a desired output stimulation signal frequency. Such output stimulation signals can have a variety of wave forms, such a pulses, charged balanced pulses, sinusoidal, square wave, triangle wave, and combinations of such basic wave forms.
In some embodiments, the stimulation source includes a pulse generator for applying signals to the microelectrodes site. The signals from the pulse generator can be connected directly to the microelectrodes, or they can be preprocessed using electronics. In some embodiments, such preprocessing electronics are embedded within the implantable device. The preprocessing electronics can filter certain parts of an original signal, such as a cardiac pacemaker signal, in order to select preferred frequency components of the original signal that are at or near a peak resistance frequency of the microelectrodes. For embodiments in which there are more microelectrodes than signals, electronics can route the stimulation signals to preferred one or more of the microelectrodes.
The width w′ of the tetrode array 522 is less than a diameter of the elongated support member 525. A height h′ of the tetrode array 522 may be the same as the width w′ or different, thereby controlling an aspect ratio of the tetrode array 522. The center-to-center spacing of adjacent tetrode array elements 522, S′ can be the same, or different measured along the length of the array. As shown, each of the sub-microelectrode elements 524 is identical and circular. In some embodiments, the tetrode elements 524 are shaped, such as polygons, ellipses, annular rings, and the like. Alternatively or in addition, one or more of the sub-microelectrode elements 524 of the tetrode array 522 may differ from other elements of the same array 522. Additionally, tetrode array elements 522 may differ in geometry, size, and configuration along the length of the elongated support member. Once again, two and three dimensional arrangements of such array elements are possible.
Beneficially, the exemplary configuration of sub-microelectrode elements may be energized in a variety of different configurations. For example, all four sub-elements 524 may be connected to the same recording or stimulation lead. Alternatively, one or more of the sub-elements 524 may be coupled to the same recording or stimulation lead (e.g., anode), while one or more of the other sub-elements of the same array 522 may be coupled to a different recording or stimulation lead (e.g., cathode). In some embodiments, one or more of the sub-microelectrode elements is connected to an electrical ground.
In some embodiments, each of the sub elements 524 of the exemplary tetrode array 522 is coupled to a respective lead. In recording mode, each sub element 524 is coupled to a respective recording lead. Thus, for each tetrode array 522, the recorder will record four separate channels Accordingly, electrophysiological activity from the same neurological target may be recorded independently through each of the independent sub elements 524 of the tetrode array 522. Dependent at least in part upon the relative location of the neurological target, the same electrophysiological activity may be recorded with different time delays, and perhaps different amplitudes. Using available signal processing techniques, the different signals recorded from two or more of the tetrode sub elements 524 can be further processed to determine relative location of the neurological target with respect to the tetrode array 522. Some exemplary techniques available for solving direction to the target include triangulation and time-difference-of-arrival, in which relative delay of the received signals, combined with knowledge of the arrangement and spacing of the sub-elements 524 can be used to solve for distances and/or angles to the target. In use, the tetrode of such a tetrode-stimulator hybrid microelectrode would be used to record neural activity from a volume of tissue immediately in front of the microelectrode. The stimulation electrode would be used to stimulate neural activity and transfer charge to that same volume of tissue.
There are several techniques to achieve the microfabricated component and the required mechanical and electrical characteristics. The fabrication procedure is a series of procedural steps in which various layers are deposited or removed (e.g., etched) to achieve a final form. Exemplary sequence of procedural steps is described herein.
Step 1: The Carrier Wafer and Sacrificial Layer
In a first step illustrated in
In some embodiments, the sacrificial layer 652, in addition to facilitating electrochemical removal of the finished device, is to establish a granularity, or grain size to the surface of the finished device. Namely, the sacrificial layer can add a micro or nano-roughness to the surface that can be precisely controlled at least in part by the selection of a suitable underlayer. For example, Aluminum can be deposited by DC Sputtering with a grain size ranging from 5 nm or less to 600 nm or more. This grain size provides a first grainy surface. A polymeric layer is subsequently deposited over the grainy sacrificial layer. This polymeric layer can be locally etched in order to create vias that open onto the grainy sacrificial layer. Subsequently, a metal layer is deposited over the resulting grainy surface, and polymeric layer, in which the deposited metal serves as the neuro-recording/stimulation microelectrode element, and wire trace. The area of the metal that falls into the via in the polymeric layer forms the microelectrode surface. The area of the metal falls on the polymeric layer can be etched into linear traces and form the interconnect between microelectrodes and bond pads or circuitry. The process is described below as a “backside microelectrode.” Due to such an increase in granularity over a relatively flat surface, the overall surface area of the metal layer will have a higher effective surface area than that area subtended by the perimeter of the element. Beneficially, the increased surface area results in a corresponding decrease in electrical impedance of the electrode element. This concept is important in that it facilitates recording, allowing a greater recording fidelity with less complexity due to the reduction in impedance, while maintaining the same small diameter that guarantees high localization of the neural activity. An electrically conducting surface of an exemplary microelectrode element thus formed is illustrated in the image of
Step 2: Deposition of First Polymeric Layer
Referring to
Referring next to
The etching can be performed by depositing a mask 656 on the first polymeric layer 654. Using well established methods for thin film processing, the mask 656 can be photolitho-graphically defined. For example, a photosensitive resin 656 is spin coated onto the polymeric layer 654. A process of exposing an unmasked portion of the resin layer 657 to UV light is used for those areas in which the operator chooses to remove the polymer layer 654. The device is developed in a solvent that will selectively remove only the unmasked areas 657 that were exposed to UV light. This selective etching process locally opens areas of the polymeric layer 654, by etching, exposing in this instance the underlayer 652. In some embodiments the device is etched in oxygen plasma to remove the exposed portion of the polymeric layer 657. The etch mask 656 may also be removed by the same etching process, but if it is thicker than the polymer layer it may not be completely removed. Illustrated in the figures is a defined etch mask 656. Alternatively or in addition, the etch mask 656 can also be implemented in a non-photodefinable layer, such as Silicon Dioxide deposited by DC Sputtering. The Silicon Dioxide then has the photoresist deposited and photolithographically defined on top of it. After etching the polymeric layer 654, the Silicon Dioxide mask can be optionally removed.
Step 3: Deposition and Definition of Metal Layer
The deposition of the layer can also be made through a resist mask 670, as shown in
In an alternative method, referring now to
Referring next to
In a preferred embodiment the metal layer 680, 682 is deposited with an adhesion promotion layer in contact with the polymer. For example, titanium can be sputtered onto the polyimide layer 654 in an initial partial step to improve adhesion, followed by a platinum layer deposited in an intermediate partial step, and optionally, a titanium layer may them be deposited onto the platinum layer in a subsequent partial step. This creates a Ti—Pt—Ti sandwich, where the titanium is responsible for adhering the platinum to the polyimide on either side of it, and the platinum is the metal layer that will be used.
For embodiments that produce backside electrodes, as described above in reference to
Step 4: Deposition of 2nd Polymeric Layer
Referring next to
Step 5: Definition of Polymeric Layers
Referring next to
The wafer 650 at this point also has a hard mask 693 deposited, for example, by DC or RF sputtering. A photodefinable 695 resist is deposited on the hard mask 693 and the areas of the polymer 654, 691 that are to be etched are defined.
The hard mask 693 is then etched with a different gas then would be used to etch the polymeric layer 654, 691, for example CF4 plasma. Now the one or more polymeric layer 654, 691 can be etched with a gas, such as oxygen plasma, to the sacrificial layer 652, as shown. Thus, the remaining portions of the hard mask shown in
The remaining portions of the hard mask 693 can be optionally removed in a subsequent step. The goal of this etching process is to: (i) define the microelectrode sites; (ii) define the device shape; and (iii) define the contact areas for electronics or wire attachment. A top view of an exemplary finished microelectrode device is shown in
If the option of making backside electrodes is taken in step 2, the device will have microelectrodes at its surface once removed from the substrate. Such a device is shown in
Step 6: Optional Bonding of Electronics
If the device is to be integrated with electronics, referring now to
Step 7: Removal of Devices from Carrier Wafer
A final step of the fabrication process is illustrated in
In some embodiments, a rigid back 642 (
The electronic components of the device enable: (i) recording of neural activity from the microelectrode array to identify which microelectrode sites are closest to the stimulation region of interest; and (ii) stimulation and modulation of neuronal activity with the microelectrode array and the ability to select which microelectrode sites stimulating.
The electronics can be implemented using discrete components, integrated circuit technology, or a combination of both. A black box design of the electronics is shown below. The electronics can be driven by an existing Implantable Pulse Generator (IPG), but will include a telemetric programming interface to properly condition or route the signal from the IPG to the microelectrode array. An embodiment of the electronic components exists which does not require the IPG.
The mechanical components and associated assembly processes serve to house the device in a hermetic and biocompatible manner. They also enable connection to an existing Implantable Pulse Generator or the extra-corporeal control unit. The extra-corporeal unit provides power, programming ability and retrieval of information. It can be implanted much like the external cochlear stimulation systems that exist today. In an embodiment that includes an Implantable Pulse Generator, it would serve to retrieve information and program the electrical unit to route the signals from the IPG to the microelectrode array.
Referring to
Referring to
In some embodiments, the signal conditioner 848 include a filtering circuit to pre-filter or gain adjust (e.g., pre-amplify and/or attenuate) or otherwise condition an existing signal before routing it to a microelectrode array. Several popular filter options include digital filters, such as infinite impulse response (IIR) filters, electronic filters using one or more electrical components, such as inductors and capacitors, and surface acoustic wave (SAW) devices. The filters can be designed through well known filter synthesis techniques to have a preferred performance features. Some of the controllable features in filter synthesis include filtration bandwidth, corner frequency, pass-band ripple, and relative sideband level. Such filters include categories referred to as Butterworth, Chebyshev 1 and 2, and Elliptic filters. The particular implementation—whether analog or digital, passive or active, makes little difference as the output from any implementation would still match the desired output.
The impedance analyzer 816 can use any of various known techniques for measuring electrical impedance. Generally, the impedance analyzer 816 provides a test electrical signal having known or measurable attributes to the microelectrode-tissue interface. Such attributes include a voltage level of a voltage source, or a current level of a current source. The test voltage or current, as the case may be, when applied to the microelectrode-tissue interface, induces a sensed current or voltage according to physical properties of the microelectrode-tissue interface. The impedance analyzer 816 can form a ratio of the test signal to the sensed signal, yielding an impedance value according to Ohm's Law: Z=V/I. As the microelectrode-tissue impedance Z is a complex quantity, each of the test and sensed electrical signals is identified as having both a magnitude and a phase.
In operation, the impedance analyzer measures a complex impedance of the microelectrode-tissue interface surrounding the at least one microelectrode 815. The impedance analyzer repeats the measurements at multiple different frequencies, by varying frequency of the applied test electrical signal. Preferably, the multiple frequencies span a frequency range that includes biologically relevant frequencies. The preferred frequency detector 817 identifies the measured impedance being closest to a pure resistance. Such a determination can be accomplished by identifying the measured impedance value having a phase value closest to zero. For example, a measured impedance can be identified having minimum absolute value phase (i.e., MIN |∠Z|). Such a determination can also be accomplished by identifying the measured impedance value having a minimum reactance (i.e., MIN(Im{Z})). The frequency at which the impedance determined to be closest to a pure resistance is identified as a preferred stimulation frequency. The stimulator 818 is then adjusted to provide a stimulation signal at a frequency, or frequency band, at or near the preferred stimulation frequency. The stimulation signal is then applied to the microelectrode array 815.
A top view of an exemplary embodiment of a microelectrode assembly 920 is illustrated in
In some embodiments, the first electronic circuitry 928 is connected to an implanted pulse generator (not shown) through a cable 924. In some embodiments, as shown, a second electronics assembly (or a portion of the first electronics assembly) includes telemetry circuitry 939, such as a telemetry antenna. In the exemplary embodiment, at least a portion of electronic circuitry 928, 938 is positioned adjacent to the microelectrodes 922, for example being joined by the elongated probe substrate 924.
The mechanical components and associated assembly processes serve to house the assembly 920 in a hermetic and biocompatible manner. They may also enable connection to an existing Implantable Pulse Generator or the extra-corporeal control unit. The extra-corporeal unit can provide power, programming ability, and retrieval of information. In some embodiments, the assembly 920 can be implanted much like currently available external cochlear stimulation systems. In an embodiment that includes an implantable pulse generator, it would serve to retrieve information and program the electrical unit to route the signals from the implantable pulse generator to the microelectrode array 922.
The device provides highly localized and efficient stimulation by incorporating microfabricated components, electronic components and mechanical components. The microfabricated component consists of a microelectrode array. This array can be implemented in a polymeric material such as polyimide, polyurethane, parylene, or polysiloxane (silicone) and includes thin film or plated layers of a metal or metal oxide with high charge transfer capability such as platinum, platinum-iridium, iridium, iridium oxide or titanium. The polymeric and metallic layers can be deposited sequentially and formed using established principles of microfabrication such as spin coating, DC/RF sputtering, photolithography, plasma etching, and etching with a mask consisting of a secondary or sacrificial material such as silicon dioxide or photosensitive resist. The metallic layer can be formed to create the microelectrode arrays and traces which connect the array to the electronics and housing. The polymeric layers serve to isolate the traces from each other but also provide the structure of the implant's stimulating/recording tip. There are several fabrication methods which can be described to build such a microfabricated component.
The electronic or microelectronic components of the device enable: (i) the ability to identify the peak resistance frequency for each individual microelectrode site using electrical impedance spectroscopy; (ii) stimulate at the characteristic peak resistance frequency of each microelectrode (this guarantees minimized signal distortion and maximum charge transfer to the tissue); and (iii) stimulation and modulation of neuronal activity with the microelectrode array and the ability to select which microelectrode sites are stimulating.
The electronics can be implemented using discrete components, integrated circuit technology, digital signal processing (DSP), or a combination of all three. The electronics can be incorporated in one unit, or can be used in conjunction with an existing implantable pulse generator (IPG). The electronics may include a telemetric programming interface to properly condition or route the signal from the IPG to the microelectrode array.
Referring to
The electronics assembly can include an electrical grounding lead for interconnection to an electrical ground potential 958. In any of the embodiments described herein, impedance measurements and/or stimulation can be implemented between two or more microelectrodes (e.g., adjacent microelectrodes). Alternatively or in addition, impedance measurements and/or stimulation can be implemented between one or more microelectrodes and an electrical ground reference.
Note that a device can be assembled to not include electronics. This device would then transfer the signal from the Implantable Pulse Generator directly to the electrodes. A device with electronics would first “pre-filter” the signal before applying to the electronics. This “pre-filter” might take the form of signal filtering in order to achieve a certain signal spectrum, multiplexing and routing in order to direct signals from a pulse generator to a choice of microelectrode sites. The following figures demonstrate the different components and embodiments.
Various exemplary embodiments of microelectrode array element configurations including tetrode arrangements are illustrated in
In general, the open areas 1006 can have any shape, and the shape need not be the same as the shape of any recording electrode 1004 that may be positioned therein. In the exemplary embodiments, the open areas 1006 do have a similar shape, namely a circle, as the disc-shaped recording electrodes 1004. The openings are dimensioned larger than the recording electrodes 1004, such that the recording electrodes can be placed within the open areas 1006, without touching the stimulation electrode 1002. An annular region of separation exists between the two electrodes 1002, 1004. The recording electrodes 1004 may each be similarly shaped and/or similarly sized with respect to each other. They may have similar shape as the stimulation electrode 1002, or have a different shape. In some embodiments, at least some of the recording electrodes 1004 have different shapes and/or different sizes with respect to each other.
In the exemplary embodiment, the four disc electrodes 1004 embedded within the larger, stimulation electrode 1002. The recording electrodes 1004 each have a respective diameter of about 50 μm, and a relative separation to their nearest neighbors of about 150 μm. The stimulation electrode has a diameter of 300 μm. In some embodiments, the diameter of each recording electrode can range between about 2 μm or less, and about 300 μm or more. In some embodiments, the diameter of the stimulation electrode can range between about 5 μm or less, and about 1,000 μm or more.
Referring to
Referring to
Referring to another microelectrode element embodiment 1030 illustrated in
Various embodiments of neurological stimulation devices and techniques have been described herein. These embodiments are given by way of example and are not intended to limit the scope of the present invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments.
One or more of any of the microelectrode array elements 1000, 1010, 1020, 1030 described above can be positioned on an elongated cylindrical member, forming a microelectrode array. Alternatively or in addition, one or more of any of the microelectrode array elements 1000, 1010, 1020, 1030 described above can be positioned on an elongated planar member, also forming a microelectrode array. An exemplary planar probe extension 1040 is illustrated in
Another alternative embodiment of a planar probe extension 1050 is illustrated in
Various embodiments of micro-fabricated neurostimulation devices have been described herein. These embodiments are giving by way of example and are not intended to limit the scope of the present invention. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the invention.
Although some devices described herein are identified as either cutaneous or chronic, it is understood that such cutaneous devices may be used in chronically, being implanted for extended periods, or even indefinitely. Similarly, any devices described herein as being chronic, it is understood that such devices may also be used cutaneously.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2009/007715 | 11/12/2009 | WO | 00 | 8/1/2011 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2010/055421 | 5/20/2010 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4245645 | Arseneault et al. | Jan 1981 | A |
4550733 | Liss et al. | Nov 1985 | A |
4837049 | Byers et al. | Jun 1989 | A |
4917093 | Dufresne et al. | Apr 1990 | A |
4969468 | Byers et al. | Nov 1990 | A |
5215088 | Normann et al. | Jun 1993 | A |
5391250 | Cheney et al. | Feb 1995 | A |
5419777 | Hofling | May 1995 | A |
5496369 | Howard | Mar 1996 | A |
5628317 | Starkebaum et al. | May 1997 | A |
5643330 | Holsheimer et al. | Jul 1997 | A |
5683422 | Rise | Nov 1997 | A |
5697651 | Fernandes | Dec 1997 | A |
5697975 | Howard et al. | Dec 1997 | A |
5702429 | King | Dec 1997 | A |
5713922 | King | Feb 1998 | A |
5713923 | Ward et al. | Feb 1998 | A |
5716377 | Rise et al. | Feb 1998 | A |
5727552 | Ryan | Mar 1998 | A |
5752979 | Benabid | May 1998 | A |
5782798 | Rise | Jul 1998 | A |
5792186 | Rise | Aug 1998 | A |
5797970 | Pouvreau | Aug 1998 | A |
5800474 | Benabid et al. | Sep 1998 | A |
5800535 | Howard, III | Sep 1998 | A |
5814092 | King | Sep 1998 | A |
5824029 | Weijand et al. | Oct 1998 | A |
5833709 | Rise et al. | Nov 1998 | A |
5833714 | Loeb | Nov 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5893883 | Torgerson et al. | Apr 1999 | A |
5913882 | King | Jun 1999 | A |
5927277 | Baudino et al. | Jul 1999 | A |
5941906 | Barreras et al. | Aug 1999 | A |
5957958 | Schulman et al. | Sep 1999 | A |
5975085 | Rise | Nov 1999 | A |
5978702 | Ward et al. | Nov 1999 | A |
5991668 | Leinders et al. | Nov 1999 | A |
6011996 | Gielen et al. | Jan 2000 | A |
6018682 | Rise | Jan 2000 | A |
6038480 | Hrdlicka et al. | Mar 2000 | A |
6050992 | Nichols | Apr 2000 | A |
6094598 | Elsberry et al. | Jul 2000 | A |
6104960 | Duysens et al. | Aug 2000 | A |
6109269 | Rise et al. | Aug 2000 | A |
6125300 | Weijand et al. | Sep 2000 | A |
6128537 | Rise | Oct 2000 | A |
6129685 | Howard, III | Oct 2000 | A |
6161047 | King et al. | Dec 2000 | A |
6205359 | Boveja | Mar 2001 | B1 |
6205361 | Kuzma et al. | Mar 2001 | B1 |
6216043 | Swanson et al. | Apr 2001 | B1 |
6227203 | Rise et al. | May 2001 | B1 |
6253109 | Gielen | Jun 2001 | B1 |
6253110 | Brabec et al. | Jun 2001 | B1 |
6263237 | Rise | Jul 2001 | B1 |
6266564 | Hill et al. | Jul 2001 | B1 |
6295476 | Schaenzer | Sep 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6330466 | Hofmann et al. | Dec 2001 | B1 |
6337997 | Rise | Jan 2002 | B1 |
6343226 | Sunde et al. | Jan 2002 | B1 |
6353762 | Baudino et al. | Mar 2002 | B1 |
6356784 | Lozano et al. | Mar 2002 | B1 |
6356786 | Rezai et al. | Mar 2002 | B1 |
6356787 | Rezai et al. | Mar 2002 | B1 |
6366813 | DiLorenzo | Apr 2002 | B1 |
6374140 | Rise | Apr 2002 | B1 |
6375666 | Mische | Apr 2002 | B1 |
6379353 | Nichols | Apr 2002 | B1 |
6434431 | Camps et al. | Aug 2002 | B1 |
6479999 | DeMeester et al. | Nov 2002 | B1 |
6484059 | Gielen | Nov 2002 | B2 |
6529774 | Greene | Mar 2003 | B1 |
6538443 | Morich et al. | Mar 2003 | B2 |
6549812 | Smits | Apr 2003 | B1 |
6556873 | Smits | Apr 2003 | B1 |
6560472 | Hill et al. | May 2003 | B2 |
6560486 | Osorio et al. | May 2003 | B1 |
6587733 | Cross et al. | Jul 2003 | B1 |
6591128 | Wu et al. | Jul 2003 | B1 |
6594524 | Esteller et al. | Jul 2003 | B2 |
6597953 | Boling | Jul 2003 | B2 |
6643552 | Edell et al. | Nov 2003 | B2 |
6671544 | Baudino | Dec 2003 | B2 |
6675046 | Holsheimer | Jan 2004 | B2 |
6687538 | Hrdlicka et al. | Feb 2004 | B1 |
6690973 | Hill et al. | Feb 2004 | B2 |
6708064 | Rezai | Mar 2004 | B2 |
6718208 | Hill et al. | Apr 2004 | B2 |
6718211 | Smits | Apr 2004 | B2 |
6741893 | Smits | May 2004 | B2 |
6745079 | King | Jun 2004 | B2 |
6757970 | Kuzma et al. | Jul 2004 | B1 |
6795737 | Gielen et al. | Sep 2004 | B2 |
6804552 | Thompson et al. | Oct 2004 | B2 |
6829498 | Kipke et al. | Dec 2004 | B2 |
6850802 | Holsheimer | Feb 2005 | B2 |
6871098 | Holsheimer et al. | Mar 2005 | B2 |
6882881 | Lesser et al. | Apr 2005 | B1 |
6892097 | Holsheimer | May 2005 | B2 |
6892438 | Hill et al. | May 2005 | B1 |
6904306 | Wu et al. | Jun 2005 | B1 |
6909920 | Lokhoff et al. | Jun 2005 | B2 |
6920359 | Meadows et al. | Jul 2005 | B2 |
6928320 | King | Aug 2005 | B2 |
6950706 | Rodriguez et al. | Sep 2005 | B2 |
6950709 | Baudino | Sep 2005 | B2 |
6978171 | Goetz et al. | Dec 2005 | B2 |
6978178 | Sommer et al. | Dec 2005 | B2 |
6999819 | Swoyer et al. | Feb 2006 | B2 |
7006859 | Osorio et al. | Feb 2006 | B1 |
7010351 | Firlik et al. | Mar 2006 | B2 |
7010356 | Jog et al. | Mar 2006 | B2 |
7024246 | Acosta et al. | Apr 2006 | B2 |
7035690 | Goetz | Apr 2006 | B2 |
7047082 | Schrom et al. | May 2006 | B1 |
7047084 | Erickson et al. | May 2006 | B2 |
7050856 | Stypulkowski | May 2006 | B2 |
7051419 | Schrom et al. | May 2006 | B2 |
7061240 | Ham et al. | Jun 2006 | B2 |
7076292 | Forsberg | Jul 2006 | B2 |
7077822 | Howard, III | Jul 2006 | B1 |
7107104 | Keravel et al. | Sep 2006 | B2 |
7133718 | Bakken et al. | Nov 2006 | B2 |
7146222 | Boling | Dec 2006 | B2 |
7151961 | Whitehurst et al. | Dec 2006 | B1 |
7174219 | Wahlstrand et al. | Feb 2007 | B2 |
7177701 | Pianca | Feb 2007 | B1 |
7181288 | Rezai et al. | Feb 2007 | B1 |
7184829 | Hill et al. | Feb 2007 | B2 |
7187978 | Malek et al. | Mar 2007 | B2 |
7191016 | Marshall et al. | Mar 2007 | B2 |
7191018 | Gielen et al. | Mar 2007 | B2 |
7203548 | Whitehurst et al. | Apr 2007 | B2 |
7204833 | Osorio et al. | Apr 2007 | B1 |
7209787 | DiLorenzo | Apr 2007 | B2 |
7212851 | Donoghue | May 2007 | B2 |
7212867 | Van Venrooij et al. | May 2007 | B2 |
7214189 | Zdeblick | May 2007 | B2 |
7216000 | Sieracki et al. | May 2007 | B2 |
7216001 | Hacker et al. | May 2007 | B2 |
7231256 | Wahlstrand et al. | Jun 2007 | B2 |
7236822 | Dobak, III | Jun 2007 | B2 |
7242984 | DiLorenzo | Jul 2007 | B2 |
7280867 | Frei et al. | Oct 2007 | B2 |
7282030 | Frei et al. | Oct 2007 | B2 |
7282050 | Starkebaum et al. | Oct 2007 | B2 |
7286878 | Stypulkowski | Oct 2007 | B2 |
7286882 | Cole | Oct 2007 | B2 |
7288066 | Drew | Oct 2007 | B2 |
7289851 | Gunderson et al. | Oct 2007 | B2 |
7289852 | Helfinstine et al. | Oct 2007 | B2 |
7295880 | Gielen | Nov 2007 | B2 |
7298143 | Jaermann et al. | Nov 2007 | B2 |
7313430 | Urquhart et al. | Dec 2007 | B2 |
7313440 | Miesel | Dec 2007 | B2 |
7315759 | Markowitz et al. | Jan 2008 | B2 |
7317947 | Wahlstrand et al. | Jan 2008 | B2 |
7317948 | King et al. | Jan 2008 | B1 |
7319899 | Keizer | Jan 2008 | B2 |
7319904 | Cross et al. | Jan 2008 | B2 |
7321798 | Muhlenberg et al. | Jan 2008 | B2 |
7321837 | Osorio et al. | Jan 2008 | B2 |
7322832 | Kronich et al. | Jan 2008 | B2 |
7328057 | Freas et al. | Feb 2008 | B2 |
7328068 | Spinelli et al. | Feb 2008 | B2 |
7328069 | Gerber | Feb 2008 | B2 |
7330760 | Heruth et al. | Feb 2008 | B2 |
7337010 | Howard et al. | Feb 2008 | B2 |
7343206 | Sage et al. | Mar 2008 | B2 |
7346395 | Lozano et al. | Mar 2008 | B2 |
7356369 | Phillips et al. | Apr 2008 | B2 |
7359837 | Drew | Apr 2008 | B2 |
7366572 | Heruth et al. | Apr 2008 | B2 |
7367956 | King | May 2008 | B2 |
7369891 | Augustijn et al. | May 2008 | B2 |
7369893 | Gunderson | May 2008 | B2 |
7369894 | Gerber | May 2008 | B2 |
7385443 | Denison | Jun 2008 | B1 |
7388378 | Gray et al. | Jun 2008 | B2 |
7389147 | Wahlstrand et al. | Jun 2008 | B2 |
7390311 | Hildebrand et al. | Jun 2008 | B2 |
7391257 | Denison et al. | Jun 2008 | B1 |
7392089 | Wahlstrand et al. | Jun 2008 | B2 |
7395113 | Heruth et al. | Jul 2008 | B2 |
7400927 | Litvin | Jul 2008 | B1 |
7406351 | Wesselink | Jul 2008 | B2 |
7418292 | Shafer | Aug 2008 | B2 |
7421297 | Giftakis et al. | Sep 2008 | B2 |
7427280 | Gerber | Sep 2008 | B2 |
7429938 | Corndorf | Sep 2008 | B1 |
7433734 | King | Oct 2008 | B2 |
7442183 | Baudino et al. | Oct 2008 | B2 |
7447545 | Heruth et al. | Nov 2008 | B2 |
7450996 | MacDonald et al. | Nov 2008 | B2 |
7463917 | Martinez | Dec 2008 | B2 |
7463928 | Lee et al. | Dec 2008 | B2 |
7474247 | Heinks et al. | Jan 2009 | B1 |
7479910 | Heinks et al. | Jan 2009 | B1 |
7483748 | Torgerson et al. | Jan 2009 | B2 |
7489966 | Leinders et al. | Feb 2009 | B2 |
7489970 | Lee et al. | Feb 2009 | B2 |
7491181 | Heruth et al. | Feb 2009 | B2 |
7497844 | Spear et al. | Mar 2009 | B2 |
7497863 | Solar et al. | Mar 2009 | B2 |
7502217 | Zhao et al. | Mar 2009 | B2 |
7505815 | Lee et al. | Mar 2009 | B2 |
7505869 | Hartlaub | Mar 2009 | B2 |
7515961 | Germanson et al. | Apr 2009 | B2 |
7519431 | Goetz et al. | Apr 2009 | B2 |
7519432 | Bolea et al. | Apr 2009 | B2 |
7526339 | Lahti et al. | Apr 2009 | B2 |
7526340 | Drew | Apr 2009 | B2 |
7526341 | Goetz et al. | Apr 2009 | B2 |
7529582 | DiLorenzo | May 2009 | B1 |
7529586 | Wahlstrand et al. | May 2009 | B2 |
7542803 | Heruth et al. | Jun 2009 | B2 |
7546164 | King | Jun 2009 | B2 |
7546166 | Michels et al. | Jun 2009 | B2 |
7548775 | Kipke et al. | Jun 2009 | B2 |
7548786 | Lee et al. | Jun 2009 | B2 |
7551951 | Osorio et al. | Jun 2009 | B1 |
7551960 | Forsberg et al. | Jun 2009 | B2 |
7555345 | Wahlstrand et al. | Jun 2009 | B2 |
7561921 | Phillips et al. | Jul 2009 | B2 |
7563141 | Alexander et al. | Jul 2009 | B2 |
7563541 | Howard et al. | Jul 2009 | B2 |
7578819 | Bleich et al. | Aug 2009 | B2 |
7580756 | Schulte et al. | Aug 2009 | B2 |
7582387 | Howard et al. | Sep 2009 | B2 |
7590451 | Tronnes et al. | Sep 2009 | B2 |
7590453 | Heruth et al. | Sep 2009 | B2 |
7590455 | Heruth et al. | Sep 2009 | B2 |
7591970 | Olson | Sep 2009 | B2 |
7594828 | Alexander et al. | Sep 2009 | B2 |
7594889 | St. Ores et al. | Sep 2009 | B2 |
7596399 | Singhal et al. | Sep 2009 | B2 |
7596408 | Singhal et al. | Sep 2009 | B2 |
7596415 | Brabec et al. | Sep 2009 | B2 |
7599730 | Hunter et al. | Oct 2009 | B2 |
7603161 | Wurmfeld et al. | Oct 2009 | B2 |
7603177 | Sieracki et al. | Oct 2009 | B2 |
7604629 | Gerber et al. | Oct 2009 | B2 |
7604644 | Schulte et al. | Oct 2009 | B2 |
7608458 | Soykan et al. | Oct 2009 | B2 |
7610083 | Drew et al. | Oct 2009 | B2 |
7611483 | Gerber et al. | Nov 2009 | B2 |
7614743 | Geiger | Nov 2009 | B2 |
7615015 | Coleman | Nov 2009 | B2 |
7616998 | Nuttin et al. | Nov 2009 | B2 |
7617002 | Goetz | Nov 2009 | B2 |
7620454 | Dinsmoor et al. | Nov 2009 | B2 |
7622303 | Soykan et al. | Nov 2009 | B2 |
7622988 | Denison et al. | Nov 2009 | B2 |
7623053 | Terry et al. | Nov 2009 | B2 |
7623918 | Goetz | Nov 2009 | B2 |
7623919 | Goetz et al. | Nov 2009 | B2 |
7623923 | Gerber et al. | Nov 2009 | B2 |
7623930 | Zeijlemaker et al. | Nov 2009 | B2 |
7624293 | Osorio et al. | Nov 2009 | B2 |
7628780 | Bonner et al. | Dec 2009 | B2 |
7631415 | Phillips et al. | Dec 2009 | B2 |
7632225 | Stypulkowski | Dec 2009 | B2 |
7635541 | Scott et al. | Dec 2009 | B2 |
7640059 | Forsberg et al. | Dec 2009 | B2 |
7641992 | Howard et al. | Jan 2010 | B2 |
7642013 | Howard et al. | Jan 2010 | B2 |
7647111 | Ries et al. | Jan 2010 | B2 |
7647116 | Bauhahn | Jan 2010 | B2 |
7647117 | Bauhahn | Jan 2010 | B2 |
7647121 | Wahlstrand et al. | Jan 2010 | B2 |
7650291 | Rosenfeld et al. | Jan 2010 | B2 |
7653433 | Lozano et al. | Jan 2010 | B2 |
7657318 | King et al. | Feb 2010 | B2 |
7657319 | Goetz et al. | Feb 2010 | B2 |
7660620 | Zeijlemaker et al. | Feb 2010 | B2 |
7660630 | Dudding et al. | Feb 2010 | B2 |
7662140 | Heruth et al. | Feb 2010 | B2 |
7662509 | Howard et al. | Feb 2010 | B2 |
7664551 | Cigaina | Feb 2010 | B2 |
7664552 | Wahlstrand et al. | Feb 2010 | B2 |
7668601 | Hegland et al. | Feb 2010 | B2 |
7671594 | Gray | Mar 2010 | B2 |
7676271 | Wahlstrand et al. | Mar 2010 | B2 |
7676273 | Goetz et al. | Mar 2010 | B2 |
7676274 | Hung et al. | Mar 2010 | B2 |
7680540 | Jensen et al. | Mar 2010 | B2 |
7682355 | Gerber et al. | Mar 2010 | B2 |
7682745 | Howard et al. | Mar 2010 | B2 |
7684860 | Wahlstrand et al. | Mar 2010 | B2 |
7684873 | Gerber | Mar 2010 | B2 |
7689289 | King | Mar 2010 | B2 |
7697972 | Verard et al. | Apr 2010 | B2 |
7697995 | Cross et al. | Apr 2010 | B2 |
7706124 | Zhao et al. | Apr 2010 | B2 |
7706889 | Gerber et al. | Apr 2010 | B2 |
7711421 | Shafer et al. | May 2010 | B2 |
7711428 | Janzig et al. | May 2010 | B2 |
7711436 | Stone | May 2010 | B2 |
7720548 | King | May 2010 | B2 |
7729780 | Vardiman | Jun 2010 | B2 |
7742823 | King et al. | Jun 2010 | B2 |
7756588 | Jog et al. | Jul 2010 | B2 |
7797029 | Gibson et al. | Sep 2010 | B2 |
7822483 | Stone et al. | Oct 2010 | B2 |
7853303 | Nikumb et al. | Dec 2010 | B2 |
7899539 | Whitehurst et al. | Mar 2011 | B2 |
7930035 | DiLorenzo | Apr 2011 | B2 |
7941202 | Hetke et al. | May 2011 | B2 |
7945336 | Sauter-Starace et al. | May 2011 | B2 |
7979105 | Kipke et al. | Jul 2011 | B2 |
8000794 | Lozano | Aug 2011 | B2 |
8000808 | Hegland et al. | Aug 2011 | B2 |
8032224 | Miesel et al. | Oct 2011 | B2 |
8036737 | Goetz et al. | Oct 2011 | B2 |
8099170 | Jensen et al. | Jan 2012 | B2 |
8280514 | Lozano et al. | Oct 2012 | B2 |
20020062143 | Baudino et al. | May 2002 | A1 |
20030004553 | Grill et al. | Jan 2003 | A1 |
20030023282 | Barrett et al. | Jan 2003 | A1 |
20030036780 | Barrett et al. | Feb 2003 | A1 |
20030083724 | Jog et al. | May 2003 | A1 |
20030100823 | Kipke et al. | May 2003 | A1 |
20030135253 | Kokones et al. | Jul 2003 | A1 |
20030176892 | Shalev | Sep 2003 | A1 |
20040002635 | Hargrove et al. | Jan 2004 | A1 |
20040015205 | Whitehurst et al. | Jan 2004 | A1 |
20040039434 | Schrom et al. | Feb 2004 | A1 |
20040102828 | Lowry et al. | May 2004 | A1 |
20040122335 | Sackellares et al. | Jun 2004 | A1 |
20040133390 | Osorio et al. | Jul 2004 | A1 |
20040138517 | Osorio et al. | Jul 2004 | A1 |
20040138536 | Frei et al. | Jul 2004 | A1 |
20040138720 | Naisberg et al. | Jul 2004 | A1 |
20040138722 | Carroll et al. | Jul 2004 | A1 |
20040152958 | Frei et al. | Aug 2004 | A1 |
20040172089 | Whitehurst et al. | Sep 2004 | A1 |
20040215288 | Lee et al. | Oct 2004 | A1 |
20040225335 | Whitehurst et al. | Nov 2004 | A1 |
20040249417 | Ransbury et al. | Dec 2004 | A1 |
20050004627 | Gibson et al. | Jan 2005 | A1 |
20050008660 | Kipke et al. | Jan 2005 | A1 |
20050010261 | Luders et al. | Jan 2005 | A1 |
20050021103 | DiLorenzo | Jan 2005 | A1 |
20050027284 | Lozano et al. | Feb 2005 | A1 |
20050033136 | Govari et al. | Feb 2005 | A1 |
20050038489 | Grill | Feb 2005 | A1 |
20050049655 | Boveja et al. | Mar 2005 | A1 |
20050070971 | Fowler et al. | Mar 2005 | A1 |
20050075681 | Rezai et al. | Apr 2005 | A1 |
20050113882 | Cameron et al. | May 2005 | A1 |
20050143790 | Kipke et al. | Jun 2005 | A1 |
20050154425 | Boveja et al. | Jul 2005 | A1 |
20050171558 | Abovitz et al. | Aug 2005 | A1 |
20050182455 | Thrope et al. | Aug 2005 | A1 |
20050209511 | Heruth et al. | Sep 2005 | A1 |
20050209513 | Heruth et al. | Sep 2005 | A1 |
20050209643 | Heruth et al. | Sep 2005 | A1 |
20050222642 | Przybyszewski et al. | Oct 2005 | A1 |
20050245988 | Miesel | Nov 2005 | A1 |
20060004422 | De Ridder | Jan 2006 | A1 |
20060030897 | Gilmer et al. | Feb 2006 | A1 |
20060041295 | Osypka | Feb 2006 | A1 |
20060049957 | Surgenor et al. | Mar 2006 | A1 |
20060058855 | Gill | Mar 2006 | A1 |
20060095105 | Jog et al. | May 2006 | A1 |
20060129203 | Garabedian et al. | Jun 2006 | A1 |
20060135877 | Giftakis et al. | Jun 2006 | A1 |
20060149336 | Meadows | Jul 2006 | A1 |
20060149337 | John | Jul 2006 | A1 |
20060167497 | Armstrong et al. | Jul 2006 | A1 |
20060173263 | He et al. | Aug 2006 | A1 |
20060173510 | Besio et al. | Aug 2006 | A1 |
20060178709 | Foster et al. | Aug 2006 | A1 |
20060195154 | Jaax et al. | Aug 2006 | A1 |
20060200206 | Firlik et al. | Sep 2006 | A1 |
20060212090 | Lozano et al. | Sep 2006 | A1 |
20060241717 | Whitehurst et al. | Oct 2006 | A1 |
20060258951 | Bleich et al. | Nov 2006 | A1 |
20060264777 | Drew | Nov 2006 | A1 |
20060276866 | McCreery | Dec 2006 | A1 |
20060282014 | Kipke et al. | Dec 2006 | A1 |
20060293720 | DiLorenzo | Dec 2006 | A1 |
20060293721 | Tarver et al. | Dec 2006 | A1 |
20070027498 | Maschino et al. | Feb 2007 | A1 |
20070027500 | Maschino et al. | Feb 2007 | A1 |
20070027514 | Gerber | Feb 2007 | A1 |
20070043268 | Russell | Feb 2007 | A1 |
20070060974 | Lozano | Mar 2007 | A1 |
20070067002 | Lozano | Mar 2007 | A1 |
20070067003 | Sanchez et al. | Mar 2007 | A1 |
20070088403 | Wyler et al. | Apr 2007 | A1 |
20070088404 | Wyler et al. | Apr 2007 | A1 |
20070093870 | Maschino | Apr 2007 | A1 |
20070100389 | Jaax et al. | May 2007 | A1 |
20070100392 | Maschino et al. | May 2007 | A1 |
20070100393 | Whitehurst et al. | May 2007 | A1 |
20070100398 | Sloan | May 2007 | A1 |
20070106143 | Flaherty | May 2007 | A1 |
20070123765 | Hetke et al. | May 2007 | A1 |
20070142872 | Mickle et al. | Jun 2007 | A1 |
20070150024 | Leyde et al. | Jun 2007 | A1 |
20070173890 | Armstrong | Jul 2007 | A1 |
20070173901 | Reeve | Jul 2007 | A1 |
20070173908 | Begnaud | Jul 2007 | A1 |
20070179558 | Gliner et al. | Aug 2007 | A1 |
20070185544 | Dawant et al. | Aug 2007 | A1 |
20070197892 | Shen et al. | Aug 2007 | A1 |
20070203537 | Goetz et al. | Aug 2007 | A1 |
20070203546 | Stone et al. | Aug 2007 | A1 |
20070208394 | King et al. | Sep 2007 | A1 |
20070213784 | Pless | Sep 2007 | A1 |
20070213785 | Osorio et al. | Sep 2007 | A1 |
20070213786 | Sackellares et al. | Sep 2007 | A1 |
20070225674 | Molnar et al. | Sep 2007 | A1 |
20070225773 | Shen et al. | Sep 2007 | A1 |
20070225774 | Eskandar et al. | Sep 2007 | A1 |
20070233192 | Craig | Oct 2007 | A1 |
20070249953 | Frei et al. | Oct 2007 | A1 |
20070249954 | Virag et al. | Oct 2007 | A1 |
20070250133 | Carlson et al. | Oct 2007 | A1 |
20070255323 | Werder et al. | Nov 2007 | A1 |
20070255338 | Wahlstrand | Nov 2007 | A1 |
20070255374 | Kolafa et al. | Nov 2007 | A1 |
20070255531 | Drew | Nov 2007 | A1 |
20070265683 | Ehrlich | Nov 2007 | A1 |
20070282389 | Moxon et al. | Dec 2007 | A1 |
20080021514 | Pless | Jan 2008 | A1 |
20080021517 | Dietrich | Jan 2008 | A1 |
20080027487 | Patel et al. | Jan 2008 | A1 |
20080027503 | Marrosu et al. | Jan 2008 | A1 |
20080027504 | Bedenbaugh | Jan 2008 | A1 |
20080027540 | Cumming | Jan 2008 | A1 |
20080039895 | Fowler et al. | Feb 2008 | A1 |
20080046012 | Covalin et al. | Feb 2008 | A1 |
20080046013 | Lozano | Feb 2008 | A1 |
20080077186 | Thompson et al. | Mar 2008 | A1 |
20080077191 | Morrell | Mar 2008 | A1 |
20080103547 | Okun et al. | May 2008 | A1 |
20080103548 | Fowler et al. | May 2008 | A1 |
20080103578 | Gerber | May 2008 | A1 |
20080114417 | Leyde | May 2008 | A1 |
20080119900 | DiLorenzo | May 2008 | A1 |
20080139870 | Gliner et al. | Jun 2008 | A1 |
20080140152 | Imran et al. | Jun 2008 | A1 |
20080154331 | John et al. | Jun 2008 | A1 |
20080161896 | Sauter-Starace et al. | Jul 2008 | A1 |
20080172103 | Kao et al. | Jul 2008 | A1 |
20080177196 | Burdick et al. | Jul 2008 | A1 |
20080188905 | Swartz | Aug 2008 | A1 |
20080195166 | Sun et al. | Aug 2008 | A1 |
20080195227 | Boling et al. | Aug 2008 | A1 |
20080208283 | Vetter et al. | Aug 2008 | A1 |
20080208287 | Palermo et al. | Aug 2008 | A1 |
20080215125 | Farah et al. | Sep 2008 | A1 |
20080221642 | Humayun et al. | Sep 2008 | A1 |
20080255439 | Tang et al. | Oct 2008 | A1 |
20080255647 | Jensen et al. | Oct 2008 | A1 |
20080269835 | Carlson et al. | Oct 2008 | A1 |
20080269842 | Giftakis et al. | Oct 2008 | A1 |
20080275526 | Lozano | Nov 2008 | A1 |
20080300652 | Lim et al. | Dec 2008 | A1 |
20090027504 | Lim et al. | Jan 2009 | A1 |
20090118806 | Vetter et al. | May 2009 | A1 |
20090132042 | Hetke et al. | May 2009 | A1 |
20090171416 | Firlik et al. | Jul 2009 | A1 |
20090177144 | Masmanidis et al. | Jul 2009 | A1 |
20090240314 | Kong et al. | Sep 2009 | A1 |
20090253977 | Kipke et al. | Oct 2009 | A1 |
20090292325 | Cederna et al. | Nov 2009 | A1 |
20090299174 | Wright et al. | Dec 2009 | A1 |
20090306728 | Wright et al. | Dec 2009 | A1 |
20090306729 | Doerr | Dec 2009 | A1 |
20090312770 | Kozai et al. | Dec 2009 | A1 |
20090325424 | Aarts et al. | Dec 2009 | A1 |
20100030298 | Martens et al. | Feb 2010 | A1 |
20100036468 | Decre et al. | Feb 2010 | A1 |
20100076536 | Merz et al. | Mar 2010 | A1 |
20100087853 | Kipke et al. | Apr 2010 | A1 |
20100100152 | Martens et al. | Apr 2010 | A1 |
20100114193 | Lozano et al. | May 2010 | A1 |
20100145216 | He et al. | Jun 2010 | A1 |
20100145414 | Decre et al. | Jun 2010 | A1 |
20100152747 | Padiy et al. | Jun 2010 | A1 |
20100198315 | Martens et al. | Aug 2010 | A1 |
20100274305 | Gliner et al. | Oct 2010 | A1 |
20100298908 | Vardiman | Nov 2010 | A1 |
20100298917 | Vardiman | Nov 2010 | A1 |
20100298918 | Vardiman | Nov 2010 | A1 |
20100331807 | Whitehurst et al. | Dec 2010 | A1 |
20110071766 | Dolan et al. | Mar 2011 | A1 |
20110152988 | Whitehurst et al. | Jun 2011 | A1 |
20110154655 | Hetke et al. | Jun 2011 | A1 |
20110184495 | Wang et al. | Jul 2011 | A1 |
20110190860 | Harberts et al. | Aug 2011 | A1 |
20110208225 | Martens et al. | Aug 2011 | A1 |
20110213382 | Decre et al. | Sep 2011 | A1 |
20110218417 | Boogaard et al. | Sep 2011 | A1 |
20110224765 | Harberts et al. | Sep 2011 | A1 |
20110224766 | Tol et al. | Sep 2011 | A1 |
20120004716 | Langhammer et al. | Jan 2012 | A1 |
20120059444 | Pardoel et al. | Mar 2012 | A1 |
20120109262 | Martens | May 2012 | A1 |
20120109599 | Martens | May 2012 | A1 |
20120136420 | Pardoel et al. | May 2012 | A1 |
20120150256 | Martens | Jun 2012 | A1 |
20120184837 | Martens et al. | Jul 2012 | A1 |
20120253442 | Gliner et al. | Oct 2012 | A1 |
20120277821 | Martens et al. | Nov 2012 | A1 |
20120303088 | Van Kaam et al. | Nov 2012 | A1 |
20120303089 | Martens et al. | Nov 2012 | A1 |
20120303107 | Decre et al. | Nov 2012 | A1 |
20130009691 | Blanken et al. | Jan 2013 | A1 |
20130172716 | Lozano et al. | Jul 2013 | A1 |
20130204318 | Young | Aug 2013 | A1 |
20130282090 | Decre et al. | Oct 2013 | A1 |
Number | Date | Country |
---|---|---|
0 677 743 | Oct 1995 | EP |
0 743 839 | Nov 1996 | EP |
0 892 654 | Jan 1999 | EP |
0 895 483 | Feb 1999 | EP |
0 959 942 | Dec 1999 | EP |
1 048 319 | Nov 2000 | EP |
1 062 973 | Dec 2000 | EP |
1 102 607 | May 2001 | EP |
1 257 320 | Nov 2002 | EP |
1 446 189 | Aug 2004 | EP |
1 514 576 | Mar 2005 | EP |
1 750 798 | Feb 2007 | EP |
1 890 764 | Feb 2008 | EP |
1 931 419 | Jun 2008 | EP |
1 985 579 | Oct 2008 | EP |
1 993 665 | Nov 2008 | EP |
2 046 441 | Apr 2009 | EP |
2 066 396 | Jun 2009 | EP |
2 069 003 | Jun 2009 | EP |
2 131 916 | Dec 2009 | EP |
2 167 188 | Mar 2010 | EP |
2 341 979 | Jul 2011 | EP |
2 456 513 | May 2012 | EP |
2 542 303 | Jan 2013 | EP |
2 559 454 | Feb 2013 | EP |
2 620 179 | Jul 2013 | EP |
2 623 154 | Aug 2013 | EP |
2 626 108 | Aug 2013 | EP |
2 626 109 | Aug 2013 | EP |
2 626 110 | Aug 2013 | EP |
2 626 111 | Aug 2013 | EP |
2 656 875 | Oct 2013 | EP |
2 656 876 | Oct 2013 | EP |
2 674 193 | Dec 2013 | EP |
WO-9810010 | Mar 1998 | WO |
WO-03022354 | Mar 2003 | WO |
WO-03028521 | Apr 2003 | WO |
WO-2004045707 | Jun 2004 | WO |
WO-2005002467 | Jan 2005 | WO |
WO-2005067792 | Jul 2005 | WO |
WO-2005112216 | Nov 2005 | WO |
WO-2007002144 | Jan 2007 | WO |
WO-2007009070 | Jan 2007 | WO |
WO-2007011611 | Jan 2007 | WO |
WO-2007025356 | Mar 2007 | WO |
WO-2007042999 | Apr 2007 | WO |
WO-2007092330 | Aug 2007 | WO |
WO-2007100428 | Sep 2007 | WO |
WO-2007108718 | Sep 2007 | WO |
WO-2008003318 | Jan 2008 | WO |
WO-2008005478 | Jan 2008 | WO |
WO-2008016881 | Feb 2008 | WO |
WO-2008035285 | Mar 2008 | WO |
WO-2008035344 | Mar 2008 | WO |
WO-2008051463 | May 2008 | WO |
WO-2008068759 | Jun 2008 | WO |
WO-2008075294 | Jun 2008 | WO |
WO-2008077440 | Jul 2008 | WO |
WO-2008089726 | Jul 2008 | WO |
WO-2008109298 | Sep 2008 | WO |
WO-2008133616 | Nov 2008 | WO |
WO-2008133683 | Nov 2008 | WO |
WO-2008138305 | Nov 2008 | WO |
WO-2011115999 | Sep 2011 | WO |
Entry |
---|
International Preliminary Report on Patentability for PCT/IB2009/007715 dated May 17, 2011. |
International Search Report for PCT/IB2009/007715 dated Apr. 22, 2010. |
Examination Report for EP 09795810.2 dated Jun. 22, 2012. |
Written Opinion for Singapore Application No. 201103393-3 dated May 2, 2012. |
Written Opinion of the International Search Authority for PCT/IB2009/07715 dated May 12, 2011. |
European Communication mailed May 22, 2013 including search report for EP application No. 12198290.4-1652. |
Notice of Reasons for Rejection for Japanese Patent Application No. 2011-543841 dated May 30, 2013. |
European Communication and Search Report for Application No. 09795810.2 dated Sep. 25, 2013, 5 pages. |
English translation of Notice of Reasons for Rejection in JP application No. 2011-543841 dated Oct. 21, 2013. |
Rousche, et al., “Flexible polyimide-based intracortical electrode arrays with bioactive capability,” IEEE Transactions on Biomedical Engineering 48(3): 361-371 (Mar. 2001). |
Sepulveda et al., “Finite Element Analysis of Current Pathways with Implanted Electrodes”, J. Biomed. Eng. 1983, vol. 5, pp. 41-48. |
Australian Patent Examination Report No. 1 dated Jan. 31, 2014 in corresponding Australian Application No. 2009315316, 3 pages. |
Number | Date | Country | |
---|---|---|---|
20110301665 A1 | Dec 2011 | US |
Number | Date | Country | |
---|---|---|---|
61113912 | Nov 2008 | US |